US healthcare company Medline has agreed to acquire the SensiCare and Aloe Vesta collection of skin care product lines from British medical products company ConvaTec for $29 million.

Medline said that through the transaction it will gain a well-established brand of patient cleansing, moisturizing and skin protectants into its portfolio of advanced skin care products. The deal is likely to be closed in Q3 2020.

Alyson Ovitt – vice president of Medline Skin Health division said: “We are really excited to bring SensiCare and Aloe Vesta into Medline’s Skin Care portfolio. Our holistic skin health solution has a particularly strong focus on preventative care with our skin care products at the core.

“We have built a highly consultative approach that helps healthcare providers optimize product utilization while also delivering specialized product solutions for specific patient populations. The SensiCare and Aloe Vesta product lines are a perfect fit.”

According to Medline, the transaction includes the Aloe Vesta and SensiCare skin care business in the US and Canada besides giving it the global rights to market the brands outside North America.

  Aloe Vesta, Alyson Ovitt, ConvaTec, Medline, SensiCare, United Kingdom, USA